Lawmakers on both sides of the aisle slammed pharmacy benefit managers for allegedly profiting at the expense of patients and taxpayers during a House oversight hearing on Tuesday, the latest congressional inquiry into PBMs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,